Sign in Subscribe
Health care industry

Japan Generic Drug Market Poised for Significant Growth

Strategic Insights

— 1 min read

The Japanese generic drug market is set to expand significantly over the next decade, driven by favorable government policies, increasing healthcare costs, and a growing acceptance of generics among healthcare providers and patients. According to a new report, the market size is expected to climb from USD 12.3 billion in 2024 to USD 22.5 billion by 2033, reflecting a compound annual growth rate (CAGR) of 6.55% during 2025-2033.

Key Takeaways:

  • The Japanese government actively endorses the use of generics to curb healthcare costs, with incentives, favorable regulations, and public campaigns promoting their use.
  • The aging population in Japan, projected to reach nearly 35% by 2040, significantly boosts demand for affordable medications, positioning the market for further expansion.
  • Healthcare costs in Japan are predicted to hit approximately 445 billion dollars by 2040, and generics, comprising 80% of prescribed drugs, are anticipated to rise as a strategic measure to manage these costs.
  • Key players leverage government incentives and a favorable regulatory framework to expand their portfolios, with technological advancements in manufacturing ensuring high-quality production and market competitiveness.
  • The market report offers thorough insights into the generic drug sector in Japan, examining value and volume trends, the COVID-19 impact, and projections through 2033.
  • The report highlights the need for stable supply chains, with the health ministry advocating for smaller drugmakers to merge with larger counterparts to ensure a stable supply amid shortages.

Statistics:

  • Market size: USD 12.3 billion in 2024, projected to reach USD 22.5 billion by 2033 (CAGR: 6.55% during 2025-2033)
  • Healthcare costs in Japan: predicted to hit approximately 445 billion dollars by 2040
  • Aging population in Japan: projected to reach nearly 35% by 2040 (according to the United Nations)
  • Generics as a percentage of prescribed drugs: 80% (according to Meiji)

Sources:

  • "Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033" (ResearchAndMarkets.com)
  • Japan Times, 2024 article on healthcare ministry's advocacy for smaller drugmakers to merge with larger counterparts
  • Meiji, report on the Japanese generic drug market
  • United Nations, demographics data on Japan's aging population

Read more